Jauculan, Rose Mae L.

HRN: 27-17-37  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/31/2025
06/05/2025
IV
4.5gms
Q8
Cellulitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: